Dong Y - Search Results

1

Nocturnal systolic hypertension is a risk factor for cardiac damage in the untreated masked hypertensive patients.

Li J, Cao Y, Liu C, Li J, Yao F, Dong Y, Huang H. Li J, et al. Among authors: dong y. J Clin Hypertens (Greenwich). 2019 Nov;21(11):1666-1674. doi: 10.1111/jch.13711. Epub 2019 Sep 26. J Clin Hypertens (Greenwich). 2019. PMID: 31556221 Free PMC article.

2

The oxidation ratio of LDL: a predictor for coronary artery disease.

Huang H, Mai W, Liu D, Hao Y, Tao J, Dong Y. Huang H, et al. Among authors: dong y. Dis Markers. 2008;24(6):341-9. doi: 10.1155/2008/371314. Dis Markers. 2008. PMID: 18688083 Free PMC article.

3

B-type natriuretic peptide attenuates cardiac hypertrophy via the transforming growth factor-ß1/smad7 pathway in vivo and in vitro.

He JG, Chen YL, Chen BL, Huang YY, Yao FJ, Chen SL, Dong YG. He JG, et al. Clin Exp Pharmacol Physiol. 2010 Mar;37(3):283-9. doi: 10.1111/j.1440-1681.2009.05281.x. Epub 2009 Aug 28. Clin Exp Pharmacol Physiol. 2010. PMID: 19719752

4

Allicin protects against cardiac hypertrophy and fibrosis via attenuating reactive oxygen species-dependent signaling pathways.

Liu C, Cao F, Tang QZ, Yan L, Dong YG, Zhu LH, Wang L, Bian ZY, Li H. Liu C, et al. J Nutr Biochem. 2010 Dec;21(12):1238-50. doi: 10.1016/j.jnutbio.2009.11.001. Epub 2010 Feb 25. J Nutr Biochem. 2010. PMID: 20185286

5

Activation of AMPK inhibits cardiomyocyte hypertrophy by modulating of the FOXO1/MuRF1 signaling pathway in vitro.

Chen BL, Ma YD, Meng RS, Xiong ZJ, Wang HN, Zeng JY, Liu C, Dong YG. Chen BL, et al. Acta Pharmacol Sin. 2010 Jul;31(7):798-804. doi: 10.1038/aps.2010.73. Epub 2010 Jun 28. Acta Pharmacol Sin. 2010. PMID: 20581852 Free PMC article.

6

Metformin attenuates ventricular hypertrophy by activating the AMP-activated protein kinase-endothelial nitric oxide synthase pathway in rats.

Zhang CX, Pan SN, Meng RS, Peng CQ, Xiong ZJ, Chen BL, Chen GQ, Yao FJ, Chen YL, Ma YD, Dong YG. Zhang CX, et al. Clin Exp Pharmacol Physiol. 2011 Jan;38(1):55-62. doi: 10.1111/j.1440-1681.2010.05461.x. Clin Exp Pharmacol Physiol. 2011. PMID: 21083698

7

[Effects of AMPK on the transcriptional activity of FOXO1 and ubiquitin ligase MuRF1 expression in rat cardiomyocytes].

Chen BL, Xiong ZJ, Zhang CX, Ma YD, Meng RS, Chen GQ, Liu C, Dong YG. Chen BL, et al. Nan Fang Yi Ke Da Xue Xue Bao. 2010 Nov;30(11):2419-22. Nan Fang Yi Ke Da Xue Xue Bao. 2010. PMID: 21097394 Chinese.

8

Plasma oxidized low-density lipoprotein is an independent risk factor in young patients with coronary artery disease.

Huang Y, Hu Y, Mai W, Cai X, Song Y, Wu Y, Dong Y, Huang H, He Z, Li W, Yang Y, Rao S. Huang Y, et al. Among authors: dong y. Dis Markers. 2011;31(5):295-301. doi: 10.3233/DMA-2011-0832. Dis Markers. 2011. PMID: 22048271 Free PMC article.

9

Oxidized low-density lipoprotein cholesterol and the ratio in the diagnosis and evaluation of therapeutic effect in patients with coronary artery disease.

Huang H, Ma R, Liu D, Liu C, Ma Y, Mai W, Dong Y. Huang H, et al. Among authors: dong y. Dis Markers. 2012;33(6):295-302. doi: 10.3233/DMA-2012-00941. Dis Markers. 2012. PMID: 23089925 Free PMC article. Clinical Trial.

10

Current and former smoking and risk for venous thromboembolism: a systematic review and meta-analysis.

Cheng YJ, Liu ZH, Yao FJ, Zeng WT, Zheng DD, Dong YG, Wu SH. Cheng YJ, et al. PLoS Med. 2013;10(9):e1001515. doi: 10.1371/journal.pmed.1001515. Epub 2013 Sep 17. PLoS Med. 2013. PMID: 24068896 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19,204 results

Search Page

Filters